Delivery Order SPE2DB22D1106-SPE2DB25FFJA6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of TICOVAC 2.4 mcg/0.5 mL syringes valued at $4,904.98, with a completion date of September 30, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled from the company's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,958.00 delivery order to AmerisourceBergen Drug Corp for TICOVAC 2.4 mcg/0.5 mL syringes on August 12, 2025, with completion scheduled for September 3, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML. The order, valued at $1,856.75, has a completion date of March 4, 2024 and was awarded on February 9, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to various U.S....
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML. The contract has a ceiling value of $1,958.00 and a period of performance through July 30, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,564.64 Firm Fixed Price delivery order covers the procurement of TICOVAC 1.2 MCG/0.25 ML SYRING 0.25ML, a medical product. The contract has an ultimate completion date of March 18, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- The Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to support military treatment programs and facilities. The contract has a potential value of $3,713.52 and a completion date of March 25, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which is...
- The Defense Logistics Agency (DLA) awarded a $55,706.97 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML vaccine. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,963.54, is for the delivery of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a medical product used for healthcare purposes. The contract has a firm fixed price pricing type and a completion date of April 4, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,418.60 firm fixed-price delivery order contract is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a performance period through December 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,525.58 firm fixed-price delivery order is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a medical product. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFJA6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of TICOVAC 2.4 MCG/0.5 ML syringes valued at $54,979.12, with completion scheduled for October 2, 2025. This delivery order is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This contract represents a routine pharmaceutical supply transaction typical of the company's extensive federal procurement portfolio. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a prime vendor for the Defense Logistics Agency's medical supply chain, AmerisourceBergen serves as a critical supplier of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The company's substantial IDC authority enables it to fulfill varied federal medical procurement needs across multiple therapeutic domains through flexible delivery orders such as this one.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $55.0k | 9/11/25 |